Sitemap
Profile
About the annual report
Board of Directors
Board of Management
Companies in Group
Global presence
Key Figures
Group DKK
Group EUR
Editorial
Summary
Highlights 2004/05
Highlights of the year
After the balance sheet date
Management's review
Allergy Sector
Ingredients Sector
Chr. Hansen Group
Continuing operations
Transition to IFRS/IAS
Outlook for 2005/06
Risk management
Commercial risks
Financial risks
Corporate governance
Value drivers
Market and products
Types of allergy medicine
SLITone®
High hopes for GRAZAX®
Research and development
Research collaboration – T-Shift
House dust mites in China
Human resources
Safety, health and environment
Shareholder info
Ownership
Share price performance
Dividend policy
Share options
Annual general meeting
IR activities and calendar
The internet
Analysts
Financial report
Accounting policies
Basis of presentation
Income statement
Balance sheet
Other accounting information
Income statement
Cash flow statement
Balance sheet
Assets
Liabilities
Equity
Notes
Auditors' report
Statement by the Management
Sitemap
Definitions
Legal disclaimer
Downloads
Contact
Print